Tuberculosis Vaccine
-
{
- All
- News
-
How Tuberculosis Vaccine Resets Immune System To Lower Alzheimer's Risk: Study
The remodelling of the human brain's immune environment by the tuberculosis vaccine BCG could offer a potential biological explanation for previously observed links between the vaccine and lower Alzheimer's disease risk, according to a study.
-
Tackling Drug-Resistant Tuberculosis: Johns Hopkins' New Nasal Vaccine Boosts Effect Of Standard Antibiotics
A new nasal vaccine developed by Johns Hopkins scientists shows promise to tackle drug-resistant tuberculosis. Here are the findings of the study and the implications of the study for India.
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
New Biomarkers Offer Hope For Effective Tuberculosis Vaccine
A team of scientists led by Oxford University has made a discovery that can improve chances of developing an effective vaccine against Tuberculosis (TB).
-
Key tuberculosis vaccine trial fails, more waiting in the wings
A highly anticipated study of the first new tuberculosis vaccine in 90 years showed it offered no added benefit over the current vaccine when it came to protecting babies from TB infections, a disappointing but not entirely unexpected outcome, researchers said on Monday.
-
How Tuberculosis Vaccine Resets Immune System To Lower Alzheimer's Risk: Study
The remodelling of the human brain's immune environment by the tuberculosis vaccine BCG could offer a potential biological explanation for previously observed links between the vaccine and lower Alzheimer's disease risk, according to a study.
-
Tackling Drug-Resistant Tuberculosis: Johns Hopkins' New Nasal Vaccine Boosts Effect Of Standard Antibiotics
A new nasal vaccine developed by Johns Hopkins scientists shows promise to tackle drug-resistant tuberculosis. Here are the findings of the study and the implications of the study for India.
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
New Biomarkers Offer Hope For Effective Tuberculosis Vaccine
A team of scientists led by Oxford University has made a discovery that can improve chances of developing an effective vaccine against Tuberculosis (TB).
-
Key tuberculosis vaccine trial fails, more waiting in the wings
A highly anticipated study of the first new tuberculosis vaccine in 90 years showed it offered no added benefit over the current vaccine when it came to protecting babies from TB infections, a disappointing but not entirely unexpected outcome, researchers said on Monday.
